Oncoradiomics

Curated by Signal

Developer of AI based clinical image analysing platform

Overview

Oncoradiomics develops AI based clinical image analysing platform. The product developed is RasiomiX is a high-throughput mining platform which uses AI to extract image features, learn and apply signatures for precision diagnosis and treatment. The company has also developed DistriM, is a platform which uses machine-learning from distributed medical datasets to develop and update RadiomiX image signatures.

Key facts

Founded: 2015
Headquarters: Maastricht, Netherlands
Stage: Sign up to view
Industry: Health Technology

Contact

Email: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

Medical X
Digital medical healthcare training tool for proffesionals
Health TechnologyRotterdam, Netherlands
Wellbee
Digital practice and EHR management tool for providers
Health TechnologyUtrecht, Netherlands
Dental Adviseurs
Provider of a practice management platform for dentists
Health TechnologyEde, Netherlands

About Oncoradiomics

What does Oncoradiomics do?

Oncoradiomics develops AI based clinical image analysing platform.

Where is Oncoradiomics headquartered?

Oncoradiomics is headquartered in Maastricht, Netherlands.

When was Oncoradiomics founded?

Oncoradiomics was founded in 2015.

Which sector is Oncoradiomics in?

Oncoradiomics operates in Health Technology.

Who are Oncoradiomics's competitors?

Companies similar to Oncoradiomics include Medical X, Wellbee, and Dental Adviseurs.